Gene · 1628
Papers4,193
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 4,193
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Effects of resveratrol on in vitro circadian clock gene expression in young and older human adipose-derived progenitor cells. | Aging (Albany NY) | 2024 | 38189848 | PubTator, text mining | PubMed |
| The single-cell transcriptomic atlas and RORA-mediated 3D epigenomic remodeling in driving corneal epithelial differentiation. | Nat Commun | 2024 | 38177186 | PubTator, text mining | PubMed |
| Association of vitamin D-binding protein polymorphisms and serum 25(OH)D concentration varies among Chinese healthy infants of different VDR-FokI genotypes: A multi-centre cross-sectional study. | Nutr Bull | 2024 | 38146611 | PubTator, text mining | PubMed |
| Time-of-day-dependent variation of the human liver transcriptome and metabolome is disrupted in MASLD. | JHEP Rep | 2024 | 38125300 | PubTator, text mining | PubMed |
| A Novel Role for the Adenovirus L4 Region 22K and 33K Proteins in Adeno-Associated Virus Production. | Hum Gene Ther | 2024 | 38062776 | PubTator, text mining | PubMed |
| Pharmacological evaluation of vitamin D in COVID-19 and long COVID-19: recent studies confirm clinical validation and highlight metformin to improve VDR sensitivity and efficacy. | Inflammopharmacology | 2024 | 37957515 | PubTator, text mining | PubMed |
| Single‑cell sequencing, genetics, and epigenetics reveal mesenchymal stem cell senescence in osteoarthritis (Review). | Int J Mol Med | 2024 | 37937669 | PubTator, text mining | PubMed |
| Perspective from single-cell sequencing: Is inflammation in acute ischemic stroke beneficial or detrimental? | CNS Neurosci Ther | 2024 | 37905592 | PubTator, text mining | PubMed |
| Efficacy of vitamin D2 in maintaining serum total vitamin D concentrations and bone mineralisation in adult dogs fed a plant-based (vegan) diet in a 3-month randomised trial. | Br J Nutr | 2024 | 37671585 | PubTator, text mining | PubMed |
| COVID-19 infection and metabolic comorbidities: Mitigating role of nutritional sufficiency and drug - nutraceutical combinations of vitamin D. | Hum Nutr Metab | 2023 | 38620788 | PubTator, text mining | PubMed |
| A Mendelian randomization study of the effect of serum 25-hydroxyvitamin D levels on autoimmune thyroid disease. | Front Immunol | 2023 | 38259461 | PubTator, text mining | PubMed |
| Dynamic Evaluation of Vitamin D Metabolism in Post-Bariatric Patients. | J Clin Med | 2023 | 38202014 | PubTator, text mining | PubMed |
| Novel Insight Into the Relationship of Vitamin D Hydroxylase and Vitamin D With Obesity in Patients With Type 2 Diabetes Mellitus. | Cureus | 2023 | 38179344 | PubTator, text mining | PubMed |
| Genetic variants of ERBB4 gene and risk of gestational diabetes mellitus: a susceptibility and diagnostic nomogram study. | Front Endocrinol (Lausanne) | 2023 | 38149095 | PubTator, text mining | PubMed |
| Identification of Adenovirus E1B-55K Interaction Partners through a Common Binding Motif. | Viruses | 2023 | 38140597 | PubTator, text mining | PubMed |
| Effects of Isoflavonoid and Vitamin D Synergism on Bone Mineral Density-A Systematic and Critical Review. | Nutrients | 2023 | 38140273 | PubTator, text mining | PubMed |
| The Molecular Aspects of Functional Activity of Macrophage-Activating Factor GcMAF. | Int J Mol Sci | 2023 | 38139225 | PubTator, text mining | PubMed |
| Severe Vitamin D Deficiency-A Possible Cause of Resistance to Treatment in Psychiatric Pathology. | Medicina (Kaunas) | 2023 | 38138159 | PubTator, text mining | PubMed |
| The Association between Serum 25-Hydroxyvitamin D3 Levels and Pro-Inflammatory Markers in New-Onset Type 2 Diabetes Mellitus and Prediabetes. | Biomolecules | 2023 | 38136648 | PubTator, text mining | PubMed |
| Efficacy of HDAC Inhibitors in Driving Peroxisomal β-Oxidation and Immune Responses in Human Macrophages: Implications for Neuroinflammatory Disorders. | Biomolecules | 2023 | 38136568 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1628/papers?page=13